Patents by Inventor Suchitra Kaushik

Suchitra Kaushik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10258583
    Abstract: The present invention relates to extended release liquid compositions of guanfacine. The extended release liquid compositions of the present invention are bioequivalent to marketed extended release tablet compositions of guanfacine. Said extended release liquid compositions provide substantially similar in-vitro dissolution release profile upon storage for at least seven days. Further, the extended release liquid compositions are stable. The extended release liquid compositions are in the form of ready-to-use liquid compositions or reconstituted liquid compositions. It also relates to processes for the preparation of said extended release liquid compositions.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: April 16, 2019
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Romi Barat Singh, Kalaiselvan Ramaraju, Balaram Mondal, Ashish Kumar, Suchitra Kaushik
  • Publication number: 20180221314
    Abstract: The present invention relates to oral liquid compositions of guanfacine. The liquid compositions can be immediate release or extended release compositions. The compositions comprise guanfacine in a concentration from about 0.1 mg/mL to about 12.0 mg/mL of the composition. The liquid compositions can be in the form of ready-to use liquid compositions or reconstituted liquid compositions. It further relates to processes for the preparation of said oral liquid compositions.
    Type: Application
    Filed: April 2, 2018
    Publication date: August 9, 2018
    Inventors: Romi Barat SINGH, Kalaiselvan RAMARAJU, Balaram MONDAL, Ashish KUMAR, Suchitra KAUSHIK
  • Patent number: 9962345
    Abstract: The present invention relates to oral liquid compositions of guanfacine. The liquid compositions can be immediate release or extended release compositions. The compositions comprise guanfacine in a concentration from about 0.1 mg/mL to about 12.0 mg/mL of the composition. The liquid compositions can be in the form of ready-to use liquid compositions or reconstituted liquid compositions. It further relates to processes for the preparation of said oral liquid compositions.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: May 8, 2018
    Assignee: Sun Pharmaceutical Industries Limited
    Inventors: Romi Barat Singh, Kalaiselvan Ramaraju, Balaram Mondal, Ashish Kumar, Suchitra Kaushik
  • Publication number: 20180008539
    Abstract: The present invention relates to a gastroretentive extended release suspension composition, wherein the composition is characterized by having no substantial change in the in-vitro dissolution release profile upon storage for at least seven days. The invention also relates to processes for the preparation of said gastroretentive extended release suspension compositions.
    Type: Application
    Filed: May 1, 2015
    Publication date: January 11, 2018
    Applicant: SUN PHARMACEUTICAL INDUSTRIES LIMITED
    Inventors: Romi Barat SINGH, Ashish KUMAR, Paras P. JAIN, Suchitra KAUSHIK, Vinay KUMAR
  • Publication number: 20160346235
    Abstract: The present invention relates to oral liquid compositions of guanfacine. The liquid. compositions can be immediate release or extended release compositions. The compositions comprise guanfacine in a concentration from about 0.1 mg/mL to about 12.0 mg/mL of the composition. The liquid compositions can be in the form of ready-to use liquid compositions or reconstituted liquid compositions. It further relates to processes for the preparation of said oral liquid compositions.
    Type: Application
    Filed: May 2, 2016
    Publication date: December 1, 2016
    Inventors: Romi Barat SINGH, Kalaiselvan RAMARAJU, Balaram MONDAL, Ashish KUMAR, Suchitra KAUSHIK
  • Publication number: 20160346233
    Abstract: The present invention relates to extended release liquid compositions of guanfacine. The extended release liquid compositions of the present invention are bioequivalent to marketed extended release tablet compositions of guanfacine. Said extended release liquid compositions provide substantially similar in-vitro dissolution release profile upon storage for at least seven days. Further, the extended release liquid compositions are stable. The extended release liquid compositions are in the form of ready-to-use liquid compositions or reconstituted liquid compositions. It also relates to processes for the preparation of said extended release liquid compositions.
    Type: Application
    Filed: May 6, 2016
    Publication date: December 1, 2016
    Inventors: Romi Barat SINGH, Kalaiselvan RAMARAJU, Balaram MONDAL, Ashish KUMAR, Suchitra KAUSHIK
  • Publication number: 20070238716
    Abstract: The present invention relates to pharmaceutical formulations containing 7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methylphenylamino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid, or pharmaceutically acceptable salts thereof, and a stabilizing agent.
    Type: Application
    Filed: March 14, 2007
    Publication date: October 11, 2007
    Inventors: Ayanampudi Murthy, Korlapati Rao, Ranadeep Bokalial, Ritu Kaushik, Suchitra Kaushik